SCHEMBL19494883

SCHEMBL19494883

CN(Cc1ccccc1)Sc1cc(C(N)=O)c(NC(=O)c2cc[nH]n2)s1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CFTR P13569 1/20 0.45
▸ IKBKB O14920 2/20 0.41
▸ ALDH1A1 P00352 5/20 0.40
▸ KDM4E B2RXH2 4/20 0.40
▸ HPGD P15428 4/20 0.40
▸ MAPT P10636 4/20 0.40
▸ NPSR1 Q6W5P4 3/20 0.40
▸ MEN1 O00255 2/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ SMN1; SMN2 Q16637 2/20 0.40
▸ ALOX15 P16050 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ LMNA P02545 1/20 0.40
▸ MAPK10 P53779 1/20 0.40
▸ CHEK1 O14757 1/20 0.36
▸ USP2 O75604 1/20 0.35
▸ JAK2 O60674 1/20 0.34
▸ JAK3 P52333 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19494715 0.92 CFTR (0.38) CFTRIKBKBALDH1A1KDM4EHPGD
SCHEMBL19494641 0.89 CFTR (0.37) CFTRALDH1A1KDM4EMAPTMEN1
SCHEMBL19494339 0.85 MAPT (0.38) CFTRALDH1A1KDM4EHPGDMAPT
SCHEMBL16387385 0.84 KDM4E (0.43) CFTRIKBKBALDH1A1KDM4EHPGD
SCHEMBL19494538 0.83 MAPK8 (0.38) CFTRIKBKBALDH1A1KDM4EHPGD
SCHEMBL19494909 0.82 MAPT (0.37) CFTRALDH1A1KDM4EHPGDMAPT
SCHEMBL16263654 0.81 CFTR (0.69) CFTRIKBKBALDH1A1KDM4EHPGD
SCHEMBL19494341 0.80 IKBKB (0.42) CFTRIKBKBALDH1A1KDM4EHPGD
SCHEMBL19494408 0.75 KDM4E (0.47) CFTRALDH1A1KDM4EHPGDMAPT
SCHEMBL16246383 0.73 CFTR (0.59) CFTRALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2994463-B1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS GALAPAGOS NV (BE) 2017-10-25 — — EP disclosed
Send feedback